Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-09T09:10:40.017Z Has data issue: false hasContentIssue false

31 - Rheumatologic diseases

Published online by Cambridge University Press:  12 January 2010

By
Joe T. Kelley III  and
Doyt L. Conn
Edited by
Michael F. Lubin ,
Robert B. Smith ,
Thomas F. Dodson ,
Nathan O. Spell  and
H. Kenneth Walker
Joe T. Kelley III
Affiliation:
Sarasota, FL
Doyt L. Conn
Affiliation:
Rheumatology Division, Emory University, School of Medicine, Atlanta, GA
Michael F. Lubin
Affiliation:
Emory University, Atlanta
Robert B. Smith
Affiliation:
Emory University, Atlanta
Thomas F. Dodson
Affiliation:
Emory University, Atlanta
Nathan O. Spell
Affiliation:
Emory University, Atlanta
H. Kenneth Walker
Affiliation:
Emory University, Atlanta
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Medical Management of the Surgical Patient
A Textbook of Perioperative Medicine
 , pp. 387 - 398
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shaw, M. & Mandell, B. F.Perioperative management of selected problems in patients with rheumatic diseases. Rheum. Dis. Clin. North Am. 1999; 25: 623–638.CrossRefGoogle ScholarPubMed
Schafer, A. I.Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J. Clin. Pharmacol. 1995; 35: 209–219.CrossRefGoogle ScholarPubMed
Lind, S. E.The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547–2551.Google Scholar
Gewirtz, A. S., Miller, M. L., & Keys, T. F.The clinical usefulness of the preoperative bleeding time. Arch. Pathol. Lab. Med. 1996; 120: 353–356.Google ScholarPubMed
Connelly, C. S. & Panush, R. S.Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch. Intern. Med. 1991; 151: 1963–1966.CrossRefGoogle ScholarPubMed
Bashein, G., Nessly, M. L., Rice, A. L.et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. Arch. Intern. Med. 1991; 151: 89–93.CrossRefGoogle ScholarPubMed
An, H. S., Mikhail, W. E., Jackson, W. T.et al. Effects of hypotensive anesthesia, nonsteroidal antiinflammatory drugs, and polymethylmethacrylate on bleeding in total hip arthroplasty patients. J. Arthroplasty 1991; 6: 245–250.CrossRefGoogle ScholarPubMed
Robinson, C. M., Christie, J., & Malcolm-Smith, N.Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J. Arthroplasty 1993; 8: 607–610.CrossRefGoogle ScholarPubMed
Hench, P. S., Kendall, E. C., Slocumb, C. H.et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of the pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Proc. Staff. Meet. Mayo Clin. 1949; 24: 181.Google ScholarPubMed
Coursin, D. B. & Wood, K. E.Corticosteroid supplementation for adrenal insufficiency. J. Am. Med. Assoc. 2002; 287: 236–240.CrossRefGoogle ScholarPubMed
Esteban, N. V., Loughlin, T., Yergey, A.et al. Daily cortisol production in man determined by stable isotope dilution/mass spectrometry. J. Clin. Endocrinol. Metab. 1991; 72: 39–45.CrossRefGoogle ScholarPubMed
Krasner, A. S.Glucocorticoid-induced adrenal insufficiency. J. Am. Med. Assoc. 1999; 282: 671–676.CrossRefGoogle ScholarPubMed
Lamberts, S. W. J., Bruining, H. A., & DeJong, F. H.Corticosteroid therapy in severe illness. N. Engl. J. Med. 1997; 337: 1285–1292.CrossRefGoogle ScholarPubMed
Munck, A., Guyre, P. M., & Holbrook, N. J.Physiological fractures of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 1984; 5: 25–44.CrossRefGoogle Scholar
Fraser, C. G., Preuss, F. S., & Bigford, W. D.Adrenal atrophy and irreversible shock associated with cortisone therapy. J. Am. Med. Assoc. 1952; 149: 1542–1543.CrossRefGoogle ScholarPubMed
Lewis, L., Robinson, R. F., Yee, J.et al. Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone infusion. Ann. Intern. Med. 1953; 39: 116–125.Google Scholar
Graber, A. L., Ney, R. L., Nicholson, W. E.et al. Natural history of pituitary–adrenal recovery following long-term suppression with corticosteroids. J. Clin. Endocrinol. Metab. 1965; 25: 11–16.CrossRefGoogle ScholarPubMed
Axelrod, L.Corticosteroid therapy. Medicine 1976; 55: 39–65.CrossRefGoogle Scholar
Treadwell, B. L. J., Savage, O., Sever, E. D.et al. Pituitary–adrenal function during corticosteroid therapy. Lancet 1963; 1: 355–358.CrossRefGoogle ScholarPubMed
Jasani, M. K., Boyle, J. A., Greig, W. R.et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Quast. J. Med. 1967; 143: 261–276.Google Scholar
Meakin, J. W., Tantongco, M. S., Crabbe, J.et al. Pituitary–adrenal function following long-term steroid therapy. Am. J. Med. 1960; 29: 459–464.CrossRefGoogle Scholar
Streck, W. F. & Lockwood, D. H.Pituitary adrenal recovery following short-term suppression with corticosteroids. Am. J. Med. 1979; 66: 910–914.CrossRefGoogle ScholarPubMed
LaRochelle, G. E., LaRochelle, A. G., Ratner, R. E.et al. Recovery of the hypothalamic–pituitary–adrenal axis in patients with rheumatic diseases receiving low-dose prednisone. Am. J. Med. 1993; 326: 258–264.CrossRefGoogle Scholar
Salem, M., Tainsh, R. E., Bromberg, J.et al. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann. Surg. 1994; 219: 416–425.CrossRefGoogle ScholarPubMed
Streck, W. F. & Lockwood, D. W.Pituitary adrenal recovery following short-term suppression with corticosteroids. Am. J. Med. 1979; 66: 910–914.CrossRefGoogle ScholarPubMed
Kremer, J. M.Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Ann. Intern. Med. 2001; 134: 695–706.CrossRefGoogle ScholarPubMed
Bridges, S. L. Jr. & Moreland, L. W.Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery. Rheum. Dis. Clin. North Am. 1997; 23: 981–993.CrossRefGoogle ScholarPubMed
Bridges, S. L. Jr., Lopez-Mendez, A., Han, K. H.et al. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J. Rheumatol. 1991; 18: 984.Google ScholarPubMed
Perhala, R. S., Wilke, W. S., Clough, J. D.et al. Local infectious complications following knee joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum. 1991; 34: 146.CrossRefGoogle Scholar
Kasdan, M. L. & June, L.Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 1993; 16: 1233.Google ScholarPubMed
Sany, J., Anaya, J. M., Canovas, F.et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J. Rheumatol. 1993; 20: 1129.Google ScholarPubMed
Alarcon, G. S., Moreland, L. W., Jaffe, K.et al. The use of methotrexate perioperatively in patients with rheumatoid arthritis undergoing major joint replacement surgery: Will we ever have a consensus about its use? J. Clin. Rheumatol. 1996; 2: 86.CrossRefGoogle Scholar
Grennan, D. M., Gray, J., Loudon, J.et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Ann. Rheum. Dis. 2001; 60: 214–217.CrossRefGoogle Scholar
Howland, W. L.Methotrexate-associated bone marrow suppression following surgery. Arthritis Rheum. 1988; 31: 1586–1587.CrossRefGoogle ScholarPubMed
Buchbinder, R., Hall, S., Harkness, A.et al. Severe bone marrow failure due to low dose methotrexate. J. Rheumatol. 1988; 15: 1586–1588.Google Scholar
Gutierrez-Urena, S., Molina, J. F., Garcia, C. O.et al. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 1996; 39: 272–276.CrossRefGoogle ScholarPubMed
Wluka, A. E., Buchbinder, R., Mylvaganam, A.et al. Long-term community based methotrexate use in rheumatoid arthritis: 12 year follow up of 460 patients. J. Rheumatol. 2000; 27: 1864–1871.Google Scholar
Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Osteoporos Int. 1991; 1: 114–117.CrossRef
Hawker, G. A.The epidemiology of osteoporosis. J. Rheumatol. 1996; 23 Suppl. 45: 2–5.Google Scholar
Smith, M. D., Ross, W., & Ahern, M. J.Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J. Rheumatol. 2001; 28: 2504–2508.Google ScholarPubMed
Ross, P. D., Davis, J. W., Epstein, R. S.et al. Pre-existing fractures and bone mass predict fracture incidence in women. N. Engl. J. Med. 1995; 332: 767–773.Google Scholar
Owen, R. A., Melton, L. J. III, Ilstrup, D. M.et al. Colles' fracture and subsequent hip fracture risk. Clin. Orthop. Relat. Res. 1982; 171: 37–43.Google Scholar
Mallmin, H., Ljunghall, S., Persson, I.et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif. Tissue Int. 1993; 52: 269–272.CrossRefGoogle ScholarPubMed
Khan, S. A., deGeus, C., Holroyd, B.et al. Osteoporosis follow-up after wrist fractures following minor trauma. Arch. Intern. Med. 2001; 161: 1309–1312.CrossRefGoogle ScholarPubMed
Freedman, K. B., Kaplan, F. S., Bilder, W. B.et al. Treatment of osteoporosis: are physicians missing an opportunity? J. Bone Joint Surg. 2000; 82-A: 1063–1070.CrossRefGoogle ScholarPubMed
Broy, S. B., Bohren, A., Harrington, T.et al. Are physicians treating osteoporosis after hip fracture? Arthritis Rheum. 2000; 43: S203.Google Scholar
Wortmann, R. L. & Kelley, W. N. Gout and hyperuricemia. In Ruddy, S., Harris, E. D. Jr., & Sledge, C. B., eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia: W. B. Saunders, 2001: 1339–1376.Google Scholar
Reginato, A. J. & Reginato, A. M. Diseases associated with deposition of calcium pyrophosphate or hydroxyapatite. In Ruddy, S., Harris, E. D. Jr., & Sledge, C. B. eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia: W. B. Saunders, 2001: 1377–1390.Google Scholar
Ho, G. Jr.Gout and pseudogout in hospitalized patients. Arch. Intern. Med. 1993; 153: 2787–2790.CrossRefGoogle ScholarPubMed
Berger, R. G.Febrile presentation of calcium pyrophosphate dihydrate deposition disease. J. Rheumatol. 1988; 15: 642–643.Google ScholarPubMed
Mavrikakis, M. E.CPPD crystal deposition disease as a cause of unrecognized pyrexia. Clin. Exp. Rheumatol. 1994; 12: 419–422.Google Scholar
Roberts, W. N., Liang, M. H., Stern, S. H.Colchicine in acute gout: reassessment of risk and benefits. J. Am. Med. Assoc. 1987; 257: 1920–1922.CrossRefGoogle ScholarPubMed
Emmerson, B. T.The management of gout. N. Engl. J. Med. 1996; 334: 445–451.CrossRefGoogle ScholarPubMed
Axelrod, D. & Preston, S.Comparison of parenteral adrenocorticotrophic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum. 1988; 31: 803–805.CrossRefGoogle ScholarPubMed
Everdingen, A. A., Jacobs, J. W. G., Reesema, D. R. S.et al. Low dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. Ann. Intern. Med. 2002; 136: 1012.Google ScholarPubMed
Conn, D. L.Resolved: Low-dose prednisone is indicated as standard treatment in patients with rheumatoid arthritis. Arthritis Rheum. (Arthritis Care Res.) 2001; 45: 462–467.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Zonana-Nacach, A., Barr, S. G., Magder, L. S.et al. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000; 43: 1801–1808.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Gurley, J. P. & Bell, G. R.The surgical management of patients with rheumatoid cervical spine disease. Rheum. Dis. Clin. North Am. 1997; 23: 317–332.CrossRefGoogle ScholarPubMed
Conlon, P. W., Isdale, I. C. & Rose, B. S.Rheumatoid arthritis of the cervical spine. An analysis of 333 cases. Ann. Rheum. Dis. 1966; 25: 120–126.CrossRefGoogle ScholarPubMed
Eulderink, F. & Meijers, K. A. E.Pathology of the cervical spine in rheumatoid arthritis. A controlled study of 44 spines. J. Pathol. 1976; 120: 91–108.CrossRefGoogle ScholarPubMed
Pellicci, D. M., Ranawat, C. S., Tsairis, P.et al. A prospective study of the progression of rheumatoid arthritis of the cervical spine. J. Bone Joint Surg. Am. 1981; 63: 342–350.CrossRefGoogle ScholarPubMed
Rana, N. A.Natural history of atlantoaxial subluxation in rheumatoid arthritis. Spine 1989; 14: 1054–1056.CrossRefGoogle Scholar
Smith, P. H., Benn, R. & Sharp, J.Natural history of rheumatoid cervical subluxations. Ann. Rheum. Dis. 1972; 31: 431–439.CrossRefGoogle ScholarPubMed
Komusi, T., Munro, T. & Harth, M.Radiologic review: the rheumatoid cervical spine. Semin. Arthritis Rheum. 1985; 14: 187–195.CrossRefGoogle ScholarPubMed
Crosby, E. T.The adult cervical spine: implications for airway management. Can. J. Anaesth. 1990; 37: 77–93.CrossRefGoogle ScholarPubMed
Harris, E. D. Jr. Clinical features of rheumatoid arthritis. In Ruddy, S., Harris, E. D. Jr., & Sledge, C. B., eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia: W. B. Saunders, 2001: 967–1000.Google Scholar
Vasculitis. In Klippel, J. H. & Dieppe, P. A., eds. Rheumatology, 2nd edn. Volume 2. London: Mosby, 1998, Section 7: Chapters 17–31.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×